Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
58,553
-91.51%
|
$1,639,484
$28.98 P/Share
|
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,553
+47.78%
|
$58,553
$1.0 P/Share
|
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
11,475
-67.86%
|
$321,300
$28.98 P/Share
|
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,475
+40.43%
|
$45,900
$4.5 P/Share
|
|
Sep 14
2021
|
Sharad Mansukani Director |
SELL
Open market or private sale
|
Direct |
156,250
-11.28%
|
$4,375,000
$28.98 P/Share
|
|
Sep 14
2021
|
Sharad Mansukani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
156,250
+10.13%
|
$156,250
$1.0 P/Share
|
|
Sep 14
2021
|
Steven Sell CEO & President |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$2,800,000
$28.98 P/Share
|
|
Sep 14
2021
|
Steven Sell CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$400,000
$4.5 P/Share
|
|
Sep 14
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
73,018
-39.13%
|
$2,044,504
$28.98 P/Share
|
|
Sep 14
2021
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,018
+28.12%
|
$73,018
$1.0 P/Share
|
|
Sep 14
2021
|
John William Wulf Director |
SELL
Open market or private sale
|
Direct |
15,342
-9.44%
|
$429,576
$28.98 P/Share
|
|
Sep 14
2021
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,904,257
-8.0%
|
$501,319,196
$28.98 P/Share
|
|
Sep 09
2021
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
865,112
-0.39%
|
-
|
|
Sep 09
2021
|
Richard J Schnall Director |
SELL
Bona fide gift
|
Direct |
119,989
-100.0%
|
-
|
|
Sep 09
2021
|
Richard J Schnall Director |
BUY
Other acquisition or disposition
|
Direct |
119,989
+50.0%
|
-
|
|
Jul 14
2021
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,489
+50.0%
|
-
|
|
Apr 19
2021
|
Michelle A Gourdine Director |
BUY
Open market or private purchase
|
Direct |
5,000
+29.49%
|
$115,000
$23.0 P/Share
|
|
Apr 19
2021
|
Clay Richards Director |
BUY
Open market or private purchase
|
Direct |
21,700
+43.09%
|
$499,100
$23.0 P/Share
|
|
Apr 14
2021
|
Timothy Bensley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,945
+50.0%
|
-
|
|
Apr 14
2021
|
Joan Danieley Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+50.0%
|
-
|
|
Apr 14
2021
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,956
+4.36%
|
-
|
|
Apr 14
2021
|
Lisa Dombro Exper. & Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,956
+50.0%
|
-
|
|
Apr 14
2021
|
Michelle A Gourdine Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+50.0%
|
-
|
|
Apr 14
2021
|
Theodore Halkias Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+50.0%
|
-
|
|
Apr 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+50.0%
|
-
|
|
Apr 14
2021
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+0.56%
|
-
|
|
Apr 14
2021
|
Clay Richards Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+50.0%
|
-
|
|
Apr 14
2021
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,586
+10.68%
|
-
|
|
Apr 14
2021
|
Glenn Sobotka Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,260
+50.0%
|
-
|
|
Apr 14
2021
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,434
+50.0%
|
-
|
|
Apr 14
2021
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+0.28%
|
-
|
|
Apr 14
2021
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+5.17%
|
-
|
|
Apr 14
2021
|
Michael L Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+4.37%
|
-
|